MTD:NYE-Mettler-Toledo International Inc. (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 1302.93

Change

+29.75 (+2.34)%

Market Cap

USD 10.87B

Volume

0.15M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Mettler-Toledo International Inc is engaged in the supply of precision instruments and services. It is a provider of weighing instruments for use in laboratory, industrial and food retailing applications.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-19 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

+2.97 (+1.45%)

USD 148.68B
A Agilent Technologies Inc

-0.36 (-0.26%)

USD 43.23B
IQV IQVIA Holdings Inc

-2.50 (-1.27%)

USD 36.97B
LH Laboratory Corporation of Amer..

+1.35 (+0.54%)

USD 20.54B
DGX Quest Diagnostics Incorporated

+0.39 (+0.23%)

USD 18.67B
QGEN Qiagen NV

-0.65 (-1.66%)

USD 9.65B
CRL Charles River Laboratories

-2.75 (-1.67%)

USD 8.50B
VNRX Volitionrx Ltd

-0.01 (-1.36%)

USD 0.06B
ENZ Enzo Biochem Inc

+0.01 (+1.78%)

USD 0.03B
TMO Thermo Fisher Scientific Inc

+6.97 (+1.31%)

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

+0.08 (+-0.13%)

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
ASRP:XETRA 2.39 % 0.00 %

N/A

N/A
XMLC:F 2.27 % 0.00 %

N/A

N/A
EMOT First Trust Exchange-Trad.. 2.11 % 0.00 %

-0.03 (-0.13%)

USD 4.38M
XLVE:CA 1.82 % 0.00 %

N/A

N/A
HECO SPDR Galaxy Hedged Digita.. 0.00 % 0.95 %

-0.56 (-0.13%)

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

+0.69 (+-0.13%)

USD 6.39B
QRI:CA 0.00 % 1.06 %

N/A

N/A
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.48% 83% B 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.48% 83% B 75% C
Trailing 12 Months  
Capital Gain 9.13% 69% C- 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.13% 69% C- 47% F
Trailing 5 Years  
Capital Gain 71.39% 92% A 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 71.39% 92% A 75% C
Average Annual (5 Year Horizon)  
Capital Gain 13.33% 77% C+ 71% C-
Dividend Return 13.33% 69% C- 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 28.89% 46% F 37% F
Risk Adjusted Return 46.15% 85% B 60% D-
Market Capitalization 10.87B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 30.90 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.